Byrne Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Sell
3,027
-10
-0.3% -$1.17K 0.21% 85
2026
Q1
$365K Sell
3,037
-85
-3% -$9.81K 0.21% 89
2025
Q4
$329K Sell
3,122
-30
-1% -$2.82K 0.18% 96
2025
Q3
$265K Buy
3,152
+154
+5% +$12.7K 0.16% 98
2025
Q2
$237K Sell
2,998
-95
-3% -$7.55K 0.16% 102
2025
Q1
$278K Buy
+3,093
New +$289K 0.2% 90
2024
Q4
Sell
-3,030
Closed -$312K 83
2024
Q3
$344K Buy
+3,030
New +$360K 0.23% 82
2024
Q2
Hold
0
80
2024
Q1
Sell
-3,048
Closed -$376K 84
2023
Q4
$329K Sell
3,048
-200
-6% -$20.8K 0.25% 86
2023
Q3
$334K Hold
3,248
0.28% 81
2023
Q2
$375K Hold
3,248
0.24% 106
2023
Q1
$346K Sell
3,248
-121
-4% -$13.1K 0.25% 103
2022
Q4
$374K Sell
3,369
-300
-8% -$30.7K 0.27% 96
2022
Q3
$316K Hold
3,669
0.24% 97
2022
Q2
$335K Sell
3,669
-175
-5% -$15.5K 0.25% 83
2022
Q1
$315K Sell
3,844
-360
-9% -$28.4K 0.2% 94
2021
Q4
$322K Buy
+4,204
New +$335K 0.21% 94

Other funds holding MRK

Byrne Asset Management's MRK Position: Q2 2026 in Review

Byrne Asset Management reduced its Merck (MRK) stake by 0.33% in Q2 2026, selling an estimated $1.17K and leaving 3,027 shares worth $389K. The position accounts for 0.21% of the portfolio, ranked #85.

Byrne Asset Management first reported a position in MRK in Q4 2021 and has held it in 16 quarters since. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Byrne Asset Management held 3,027 shares of Merck worth $389K as of Q2 2026.
  • Byrne Asset Management sold 10 Merck shares in Q2 2026, an estimated $1.17K.
  • Merck made up 0.21% of Byrne Asset Management's portfolio in Q2 2026, its #85 holding.
  • Byrne Asset Management first reported a position in Merck in Q4 2021 and has held it in 16 quarters since.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.